---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-010037"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:01:59.749043+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# KALA BIO CEO Lazar sells Series AAA preferred rights; consultant hired for strategic alternatives

## Summary
- Annual meeting set for Jan 30, 2026; stockholder proposals and director nominations due Dec 27, 2025.
- David Lazar sold his rights to purchase Series AAA Preferred Shares (up to $4.2M) to unaffiliated AK Holdings Group Inc.
- Company retains consultant, a principal of AK Holdings, to advise on identifying and consummating a strategic alternative transaction.

## SEC filing metadata
- accession: 0001829126-25-010037
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- confidence: high
- sec_items: 5.08, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912625010037/0001829126-25-010037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912625010037/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-010037
- JSON: https://secwatch.observer/filing/0001829126-25-010037.json
- Plain text: https://secwatch.observer/filing/0001829126-25-010037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.